Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes

Science Immunology

Volumn 1, Issue 5, 2016, Pages

  Long, S Alice ^a   Thorpe, Jerill ^a   DeBerg, Hannah A ^a   Gersuk, Vivian ^a   Eddy, James A ^a   Harris, Kristina M ^b   Ehlers, Mario ^c   Herold, Kevan C ^d   Nepom, Gerald T ^b   Linsley, Peter S ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b Immune Tolerance Network   (United States)

^c Immune Tolerance Network   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85062702714     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aai7793     Document Type: Article

References (55)

1. M. R. Rigby, M. R. Ehlers, Targeted immune interventions for type 1 diabetes: Not as easy as it looks! Curr. Opin. Endocrinol. Diabetes Obes. 21, 271–278 (2014).
2. C. J. Greenbaum, D. A. Schatz, M. J. Haller, S. Sanda, Through the fog: Recent clinical trials to preserve b-cell function in type 1 diabetes. Diabetes 61, 1323–1330 (2012).
3. M. Wållberg, A. Cooke, Immune mechanisms in type 1 diabetes. Trends Immunol. 34, 583–591 (2013).
4. J. Crespo, H. Sun, T. H. Welling, Z. Tian, W. Zou, T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 25, 214–221 (2013).
5. A. Schietinger, P. D. Greenberg, Tolerance and exhaustion: Defining mechanisms of T cell dysfunction. Trends Immunol. 35, 51–60 (2014).
6. + T cell exhaustion versus memory. Immunity 37, 1130–1144 (2012).
7. Cancer Genome Atlas Network, Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).
8. M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, G. K. Smyth, limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
9. E. J. Wherry, M. Kurachi, Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
10. + T cell dysfunction during chronic infection. Immunity 40, 289–302 (2014).
11. E. J. Wherry, T cell exhaustion. Nat. Immunol. 12, 492–499 (2011).
12. E. F. McKinney, J. C. Lee, D. R. W. Jayne, P. A. Lyons, K. G. C. Smith, T-cell exhaustion, costimulation and clinical outcome in autoimmunity and infection. Nature 523, 612–616 (2015).
13. F. Reynier, A. Pachot, M. Paye, Q. Xu, F. Turrel-Davin, F. Petit, A. Hot, C. Auffray, N. Bendelac, M. Nicolino, B. Mougin, C. Thivolet, Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun. 11, 269–278 (2010).
14. K. C. Herold, S. E. Gitelman, M. R. Ehlers, P. A. Gottlieb, C. J. Greenbaum, W. Hagopian, K. D. Boyle, L. Keyes-Elstein, S. Aggarwal, D. Phippard, P. H. Sayre, J. McNamara, J. A. Bluestone; AbATE Study Team, Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes 62, 3766–3774 (2013).
15. P. S. Linsley, C. Speake, E. Whalen, D. Chaussabel, Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis. PLOS ONE 9, e109760 (2014).
16. N. Novershtern, A. Subramanian, L. N. Lawton, R. H. Mak, W. N. Haining, M. E. McConkey, N. Habib, N. Yosef, C. Y. Chang, T. Shay, G. M. Frampton, A. C. B. Drake, I. Leskov, B. Nilsson, F. Preffer, D. Dombkowski, J. W. Evans, T. Liefeld, J. S. Smutko, J. Chen, N. Friedman, R. A. Young, T. R. Golub, A. Regev, B. L. Ebert, Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296–309 (2011).
17. A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, J. P. Mesirov, Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545–15550 (2005).
18. A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, B. Wold, Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628 (2008).
19. A. Franceschini, D. Szklarczyk, S. Frankild, M. Kuhn, M. Simonovic, A. Roth, J. Lin, P. Minguez, P. Bork, C. von Mering, L. J. Jensen, STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808–D815 (2013).
20. J. E. Tooley, N. Vudattu, J. Choi, C. Cotsapas, L. Devine, K. Raddassi, M. R. Ehlers, J. G. McNamara, K. M. Harris, S. Kanaparthi, D. Phippard, K. C. Herold, Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes. Eur. J. Immunol. 46, 230–241 (2016).
21. S. J. Turner, P. C. Doherty, J. McCluskey, J. Rossjohn, Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6, 883–894 (2006).
22. G. B. Stewart-Jones, P. Simpson, P. A. van der Merwe, P. Easterbrook, A. J. McMichael, S. L. Rowland-Jones, E. Y. Jones, G. M. Gillespie, Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. Proc. Natl. Acad. Sci. U.S.A. 109, E3483–E3492 (2012).
23. + T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. Nat. Commun. 7, 11153 (2016).
24. S. B. G. Eckle, R. W. Birkinshaw, L. Kostenko, A. J. Corbett, H. E. G. McWilliam, R. Reantragoon, Z. Chen, N. A. Gherardin, T. Beddoe, L. Liu, O. Patel, B. Meehan, D. P. Fairlie, J. A. Villadangos, D. I. Godfrey, L. Kjer-Nielsen, J. McCluskey, J. Rossjohn, A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J. Exp. Med. 211, 1585–1600 (2014).
25. S. Porcelli, C. E. Yockey, M. B. Brenner, S. P. Balk, Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- a/b T cells demonstrates preferential use of several Vb genes and an invariant TCR a chain. J. Exp. Med. 178, 1–16 (1993).
26. N. A. Gherardin, A. N. Keller, R. E. Woolley, J. Le Nours, D. S. Ritchie, P. J. Neeson, R. W. Birkinshaw, S. B. G. Eckle, J. N. Waddington, L. Liu, D. P. Fairlie, A. P. Uldrich, D. G. Pellicci, J. McCluskey, D. I. Godfrey, J. Rossjohn, Diversity of T cells restricted by the MHC class I-related molecule MR1 facilitates differential antigen recognition. Immunity 44, 32–45 (2016).
27. M. L. Joachims, K. M. Leehan, C. Lawrence, R. C. Pelikan, J. S. Moore, Z. Pan, A. Rasmussen, L. Radfar, D. M. Lewis, K. M. Grundahl, J. A. Kelly, G. B. Wiley, M. Shugay, D. M. Chudakov, C. J. Lessard, D. U. Stone, R. H. Scofield, C. G. Montgomery, K. L. Sivils, L. F. Thompson, A. D. Farris, Single-cell analysis of glandular T cell receptors in Sjögren’s syndrome. JCI Insight 1, e85609 (2016).
28. J.-W. Du, J.-Y. Gu, J. Liu, X.-N. Cen, Y. Zhang, Y. Ou, B. Chu, P. Zhu, TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk. Lymphoma 48, 1618–1627 (2007).
29. + T cell expansion in acute EBV infection. J. Immunol. 195, 4185–4197 (2015).
30. S. A. Fuertes Marraco, N. J. Neubert, G. Verdeil, D. E. Speiser, Inhibitory receptors beyond T cell exhaustion. Front. Immunol. 6, 310 (2015).
31. V. Ablamunits, K. C. Herold, Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3g1 (Ala-Ala). Hum. Immunol. 69, 732–736 (2008).
32. + T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc. Natl. Acad. Sci. U.S.A. 108, 2010–2015 (2011).
33. + T cells are involved in development and control of human autoimmune type 1 diabetes. J. Clin. Invest. 120, 3641–3650 (2010).
34. + T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 8, 743–752 (2007).
35. + T-cell–mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo. Blood 108, 2257–2264 (2006).
36. + Tregs. J. Clin. Invest. 115, 2904–2913 (2005).
37. + NKT cell development. PLOS Pathog. 6, e1000915 (2010).
38. D. L. Barber, E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, R. Ahmed, Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).
39. + T cell exhaustion during chronic viral infection. Immunity 27, 670–684 (2007).
40. D. S. Chen, I. Mellman, Oncology meets immunology: The cancer-immunity cycle. Immunity 39, 1–10 (2013).
41. J. Hughes, N. Vudattu, M. Sznol, S. Gettinger, H. Kluger, B. Lupsa, K. C. Herold, Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. Diabetes Care 38, e55–e57 (2015).
42. P. Du, W. A. Kibbe, S. M. Lin, lumi: A pipeline for processing Illumina microarray. Bioinformatics 24, 1547–1548 (2008).
43. P. Du, W. A. Kibbe, S. M. Lin, nuID: A universal naming scheme of oligonucleotides for illumina, Affymetrix, and other microarrays. Biol. Direct 2, 16 (2007).
44. P. Langfelder, S. Horvath, WGCNA: An R package for weighted correlation network analysis. BMC Bioinf. 9, 559 (2008).
45. A. R. Wu, N. F. Neff, T. Kalisky, P. Dalerba, B. Treutlein, M. E. Rothenberg, F. M. Mburu, G. L. Mantalas, S. Sim, M. F. Clarke, S. R. Quake, Quantitative assessment of single-cell RNA-sequencing methods. Nat. Methods 11, 41–46 (2014).
46. B. Giardine, C. Riemer, R. C. Hardison, R. Burhans, L. Elnitski, P. Shah, Y. Zhang, D. Blankenberg, I. Albert, J. Taylor, W. Miller, W. J. Kent, A. Nekrutenko, Galaxy: A platform for interactive large-scale genome analysis. Genome Res. 15, 1451–1455 (2005).
47. E. Afgan, D. Baker, M. van den Beek, D. Blankenberg, D. Bouvier, M. Čech, J. Chilton, D. Clements, N. Coraor, C. Eberhard, B. Grüning, A. Guerler, J. Hillman-Jackson, G. Von Kuster, E. Rasche, N. Soranzo, N. Turaga, J. Taylor, A. Nekrutenko, J. Goecks, The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 44, W3–W10 (2016).
48. C. Trapnell, L. Pachter, S. L. Salzberg, TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
49. S. Anders, P. T. Pyl, W. Huber, HTSeq—A Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
50. M. D. Robinson, A. Oshlack, A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
51. M. D. Robinson, D. J. McCarthy, G. K. Smyth, edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
52. C. W. Law, Y. Chen, W. Shi, G. K. Smyth, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
53. M. G. Grabherr, B. J. Haas, M. Yassour, J. Z. Levin, D. A. Thompson, I. Amit, X. Adiconis, L. Fan, R. Raychowdhury, Q. Zeng, Z. Chen, E. Mauceli, N. Hacohen, A. Gnirke, N. Rhind, F. di Palma, B. W. Birren, C. Nusbaum, K. Lindblad-Toh, N. Friedman, A. Regev, Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat. Biotechnol. 29, 644–652 (2011).
54. X. Brochet, M.-P. Lefranc, V. Giudicelli, IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503–W508 (2008).
55. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, T. Ideker, Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).